125 related articles for article (PubMed ID: 10571659)
1. Nonlinearity of nuclear enlargement in hepatocytes induced by the carcinogen N'-nitrosomorpholine in Ovo.
Wiemann C; Enzmann H; Löser E; Schlüter G
Cancer Detect Prev; 1999; 23(6):485-95. PubMed ID: 10571659
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent induction of preneoplastic lesions by the tobacco-specific nitrosamine carcinogen NNK in the in ovo carcinogenicity assessment (IOCA) assay.
Enzmann HG; Brunnemann KD; Kaestner B; Iatropoulos MJ; Williams GM
Exp Toxicol Pathol; 2014 Jan; 66(1):35-40. PubMed ID: 24054761
[TBL] [Abstract][Full Text] [Related]
3. Dose dependence of diethylnitrosamine-induced nuclear enlargement in embryonal turkey liver.
Enzmann H; Kühlem C; Löser E; Bannasch P
Carcinogenesis; 1995 Jun; 16(6):1351-5. PubMed ID: 7788854
[TBL] [Abstract][Full Text] [Related]
4. In ovo carcinogenicity assay (IOCA): evaluation of mannitol, caprolactam and nitrosoproline.
Brunnemann KD; Enzmann HG; Perrone CE; Iatropoulos MJ; Williams GM
Arch Toxicol; 2002 Oct; 76(10):606-12. PubMed ID: 12373457
[TBL] [Abstract][Full Text] [Related]
5. Effects of low doses of N-nitrosomorpholine on the development of early stages of hepatocarcinogenesis.
Enzmann H; Zerban H; Kopp-Schneider A; Löser E; Bannach P
Carcinogenesis; 1995 Jul; 16(7):1513-8. PubMed ID: 7614684
[TBL] [Abstract][Full Text] [Related]
6. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced in stop experiments by oral exposure to N-nitrosomorpholine.
Weber E; Bannasch P
Carcinogenesis; 1994 Jun; 15(6):1227-34. PubMed ID: 8020160
[TBL] [Abstract][Full Text] [Related]
7. Rat hepatocarcinogenesis induced by N-nitrosodiethylamine and N-nitrosomorpholine continuously administered at low doses. From basophilic areas of hepatocytes to hepatocellular tumors.
Cortinovis C; Klimek F; Nogueira E
Am J Pathol; 1991 Nov; 139(5):1157-71. PubMed ID: 1951631
[TBL] [Abstract][Full Text] [Related]
8. Rapid induction of preneoplastic liver foci in embryonal turkey liver by diethylnitrosamine.
Enzmann H; Kühlem C; Kaliner G; Löser E; Bannasch P
Toxicol Pathol; 1995; 23(5):560-9. PubMed ID: 8578099
[TBL] [Abstract][Full Text] [Related]
9. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by continuous oral exposure to N-nitrosomorpholine.
Weber E; Bannasch P
Carcinogenesis; 1994 Jun; 15(6):1235-42. PubMed ID: 8020161
[TBL] [Abstract][Full Text] [Related]
10. Morphometric and cytophotometric nuclear analysis of altered hepatocyte foci induced by N-nitrosomorpholine (NNM) and aflatoxin B1 (AFB1) in liver of Wistar rats.
Gil R; Callaghan R; Boix J; Pellin A; Llombart-Bosch A
Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 54(6):341-9. PubMed ID: 2897742
[TBL] [Abstract][Full Text] [Related]
11. Dose and time dependence of the cellular phenotype in rat hepatic preneoplasia and neoplasia induced by single oral exposures to N-nitrosomorpholine.
Weber E; Bannasch P
Carcinogenesis; 1994 Jun; 15(6):1219-26. PubMed ID: 8020159
[TBL] [Abstract][Full Text] [Related]
12. Xenomorphic hepatocellular precursors and neoplastic progression of tigroid cell foci induced in rats with low doses of N-nitrosomorpholine.
Ströbel P; Klimek F; Zerban H; Kopp-Schneider A; Bannasch P
Carcinogenesis; 1998 Dec; 19(12):2069-80. PubMed ID: 9886559
[TBL] [Abstract][Full Text] [Related]
13. Cleavage of poly(ADP-ribose) transferase during p53-independent apoptosis in rat liver after treatment with N-nitrosomorpholine and cyproterone acetate.
Weşierska-Gadek J; Bugajska-Schretter A; Löw-Baselli A; Grasl-Kraupp B
Mol Carcinog; 1999 Apr; 24(4):263-75. PubMed ID: 10326863
[TBL] [Abstract][Full Text] [Related]
14. Enhancement and phenotypic modulation of N-nitrosomorpholine-induced hepatocarcinogenesis by dehydroepiandrosterone.
Metzger C; Bannasch P; Mayer D
Cancer Lett; 1997 Dec; 121(2):125-31. PubMed ID: 9570349
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of NNM-induced carcinogenesis in the rat liver by phenobarbital: a combined morphological and enzyme histochemical approach.
Moore MA; Hacker HJ; Kunz HW; Bannasch P
Carcinogenesis; 1983; 4(4):473-9. PubMed ID: 6132686
[TBL] [Abstract][Full Text] [Related]
16. Enhancement by ethyl alcohol of experimental hepatocarcinogenesis induced by N-nitrosomorpholine.
Tatsuta M; Iishi H; Baba M; Yano H; Iseki K; Uehara H; Nakaizumi A
Int J Cancer; 1997 Jun; 71(6):1045-8. PubMed ID: 9185709
[TBL] [Abstract][Full Text] [Related]
17. Inter-laboratory comparison of turkey in ovo carcinogenicity assessment (IOCA) of hepatocarcinogens.
Enzmann H; Brunnemann K; Iatropoulos M; Shpyleva S; Lukyanova N; Todor I; Moore M; Spicher K; Chekhun V; Tsuda H; Williams G
Exp Toxicol Pathol; 2013 Sep; 65(6):729-35. PubMed ID: 23121990
[TBL] [Abstract][Full Text] [Related]
18. Influence of the nature and the dose of the initiator on the development of premalignant and malignant lesions in rat hepatocarcinogenesis.
Préat V; de Gerlache J; Lans M; Taper H; Roberfroid M
Teratog Carcinog Mutagen; 1986; 6(3):165-72. PubMed ID: 2875529
[TBL] [Abstract][Full Text] [Related]
19. Production of liver preneoplasia and gallbladder agenesis in turkey fetuses administered diethylnitrosamine.
Williams GM; Brunnemann KD; Iatropoulos MJ; Smart DJ; Enzmann HG
Arch Toxicol; 2011 Jun; 85(6):681-7. PubMed ID: 20981410
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by verapamil of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.
Uehara H; Nakaizumi A; Baba M; Iishi H; Tatsuta M
Br J Cancer; 1993 Jul; 68(1):37-40. PubMed ID: 8100445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
